Drug Shortage Report for ENGERIX-B
Report ID | 156733 |
Drug Identification Number | 02487039 |
Brand name | ENGERIX-B |
Common or Proper name | Hepatitis B vaccine (recombinant) |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | HEPATITIS B SURFACE ANTIGEN |
Strength(s) | 20MCG |
Dosage form(s) | SUSPENSION |
Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
Packaging size | 1's |
ATC code | J07BC |
ATC description | VIRAL VACCINES |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2022-03-10 |
Estimated end date | 2022-04-04 |
Actual end date | 2022-03-31 |
Shortage status | Resolved |
Updated date | 2022-04-01 |
Company comments | Limited supply available for public programs. Supply unavailable for the private market. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2022-04-01 | English | Compare |
v7 | 2022-03-31 | English | Compare |
v6 | 2022-03-31 | French | Compare |
v5 | 2022-03-31 | English | Compare |
v4 | 2022-03-30 | French | Compare |
v3 | 2022-03-30 | English | Compare |
v2 | 2022-03-15 | French | Compare |
v1 | 2022-03-15 | English | Compare |
Showing 1 to 8 of 8